临床肝胆病杂志
臨床肝膽病雜誌
림상간담병잡지
CHINESE JOURNAL OF CLINICAL HEPATOLOGY
2015年
4期
603-606
,共4页
程萍(综述)%薛博瑜(审校)
程萍(綜述)%薛博瑜(審校)
정평(종술)%설박유(심교)
肝炎病毒,乙型%T淋巴细胞,辅助诱导%T淋巴细胞,调节性%综述
肝炎病毒,乙型%T淋巴細胞,輔助誘導%T淋巴細胞,調節性%綜述
간염병독,을형%T림파세포,보조유도%T림파세포,조절성%종술
hepatitis B virus%T-lymphocytes,helper-inducer%T-lymphocytes,regulatory%review
HBV持续感染与宿主的免疫应答相关,CD4+T淋巴细胞在HBV特异性免疫应答中起重要作用。核苷和核苷酸类药物抗病毒治疗后,HBV特异性T淋巴细胞应答的恢复与CD4+T淋巴细胞亦相关。近年来新发现CD4+T淋巴细胞的2个亚群,即调节性T淋巴细胞(Treg细胞)和辅助性T淋巴细胞(Th)17,它们与HBV持续感染相关疾病的病情进展以及肝损伤相关。初步总结了Treg和Th17的分化及功能,综述了HBV持续感染相关疾病中二者的相互关系及临床抗病毒治疗后二者的变化,旨在为临床进行免疫治疗及评估预后提供帮助。
HBV持續感染與宿主的免疫應答相關,CD4+T淋巴細胞在HBV特異性免疫應答中起重要作用。覈苷和覈苷痠類藥物抗病毒治療後,HBV特異性T淋巴細胞應答的恢複與CD4+T淋巴細胞亦相關。近年來新髮現CD4+T淋巴細胞的2箇亞群,即調節性T淋巴細胞(Treg細胞)和輔助性T淋巴細胞(Th)17,它們與HBV持續感染相關疾病的病情進展以及肝損傷相關。初步總結瞭Treg和Th17的分化及功能,綜述瞭HBV持續感染相關疾病中二者的相互關繫及臨床抗病毒治療後二者的變化,旨在為臨床進行免疫治療及評估預後提供幫助。
HBV지속감염여숙주적면역응답상관,CD4+T림파세포재HBV특이성면역응답중기중요작용。핵감화핵감산류약물항병독치료후,HBV특이성T림파세포응답적회복여CD4+T림파세포역상관。근년래신발현CD4+T림파세포적2개아군,즉조절성T림파세포(Treg세포)화보조성T림파세포(Th)17,타문여HBV지속감염상관질병적병정진전이급간손상상관。초보총결료Treg화Th17적분화급공능,종술료HBV지속감염상관질병중이자적상호관계급림상항병독치료후이자적변화,지재위림상진행면역치료급평고예후제공방조。
Persistent infection with hepatitis B virus (HBV)is associated with host immune response.CD4 +T cells play an important role in HBV-specific immune response.The restoration of HBV-specific T-cell response after antiviral therapy using nucleoside and nucleo-tide analogues is also associated with CD4 +T cells.In recent years,two new subsets of CD4 +T cells,namely regulatory T cells (Tregs) and T helper 17 cells (Th17 cells),have been identified and shown to be related to disease progression and liver damage in patients with persistent HBV infection.Here we primarily summarized the differentiation and function of Tregs and Th17 cells and reviewed the interaction between the two types of cells in persistent infection and their changes after clinical antiviral therapy.We hope it will be helpful to clinical immunotherapy and prognostic assessment.